JPMORGAN CHASE & CO - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 46 filers reported holding OMEGA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$56,120
-53.0%
26,102
+22.4%
0.00%
Q2 2023$119,408
+1094.1%
21,323
+1166.2%
0.00%
Q1 2023$10,000
+111011.1%
1,684
+8.2%
0.00%
Q4 2022$9
-99.9%
1,556
-44.0%
0.00%
Q3 2022$15,000
+114.3%
2,780
+46.1%
0.00%
Q2 2022$7,000
-93.8%
1,903
-89.6%
0.00%
Q1 2022$113,000
+10.8%
18,230
+102.8%
0.00%
Q4 2021$102,000
+92.5%
8,987
+217.3%
0.00%
Q3 2021$53,0002,8320.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$758,8235.08%
Flagship Pioneering Inc. 29,225,579$62,834,9964.56%
HARBOURVEST PARTNERS LLC 3,512,110$7,551,0372.56%
CHI Advisors LLC 1,055,882$2,270,1460.90%
Knoll Capital Management, LLC 173,010$371,9710.39%
Artal Group S.A. 2,533,045$5,4460.23%
683 Capital Management, LLC 508,242$1,092,7200.08%
PLATINUM INVESTMENT MANAGEMENT LTD 887,017$1,907,0870.07%
ORACLE INVESTMENT MANAGEMENT INC 50,000$107,5000.03%
STATE OF WISCONSIN INVESTMENT BOARD 1,857,265$3,993,1200.01%
View complete list of OMEGA THERAPEUTICS INC shareholders